|
About the Events / Workshops / Webinars category
|
|
0
|
622
|
April 14, 2021
|
|
FREE Lhasa Webinar | Nitrosaminas en el horizonte: ¿Está preparado? 🇲🇽
|
|
0
|
33
|
January 21, 2025
|
|
🇲🇽 Boot Camp de Nitrosaminas 13/14 Marzo en CDMX
|
|
41
|
402
|
January 20, 2025
|
|
SCIEX Webinar: Unlocking precision: nitrosamine and NDSRI analysis(16.1.2025 10:30 CET)
|
|
0
|
231
|
January 12, 2025
|
|
👨💻 FDA-CRCG NDSRI Workshop
|
|
2
|
804
|
January 10, 2025
|
|
CAPRA 2024 Pharmaceutical SYMPOSIUM PRESENTATIONS & MATERIALS
|
|
0
|
327
|
December 25, 2024
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
12
|
2306
|
December 13, 2024
|
|
📅 Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products(CRCG)
|
|
35
|
2892
|
December 3, 2024
|
|
Free webinar: From Ambiguity to Action, The FDA's New Nitrosamine Guidance
|
|
1
|
581
|
December 2, 2024
|
|
Small Nitrosamines in excipeints
|
|
11
|
367
|
November 21, 2024
|
|
📅 Analytical challenges and the effective management of nitrosamines: The evolving landscape of NDSRI analysis
|
|
3
|
503
|
October 30, 2024
|
|
AAPS PharmSci360 -Nitrosamines
|
|
13
|
432
|
October 22, 2024
|
|
Royal Australian Chemical Institute
|
|
0
|
80
|
September 26, 2024
|
|
57th Congress of the European Societies of Toxicology (EUROTOX 2023)
|
|
2
|
687
|
September 24, 2024
|
|
Facing Up to the New Nemesis of Pharma: Nitrosamines What’s going on with nitrosamines in pharmaceutical products? Naiffer Romero, Principal Scientist at the US Pharmacopeia walks us through frequently asked questions
|
|
0
|
183
|
September 23, 2024
|
|
9th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
0
|
355
|
September 18, 2024
|
|
PMDA-USP Workshop - Nitrosamines Track
|
|
2
|
498
|
September 17, 2024
|
|
FDA-CDER and HESI | Nitrosamine Ames Data Review and Method Development Workshop
|
|
1
|
247
|
September 17, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
22
|
1627
|
September 5, 2024
|
|
📅 FDA - CRCG Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products -Event
|
|
1
|
961
|
August 14, 2024
|
|
IPEC Webinar on the role of excipients in determine N-nitrosamine risks
|
|
3
|
452
|
July 24, 2024
|
|
Classification of potentially mutagenic impurities under the ICH M7 guideline -Event
|
|
0
|
382
|
July 23, 2024
|
|
Nitrosamine in vivo mutagenicity workshop
|
|
10
|
768
|
July 22, 2024
|
|
Nitrosamine impurities in medicines (presented at the ARCS Annual Conference 2024)
|
|
12
|
1082
|
July 17, 2024
|
|
USP India - Nitrosamines panel discussion at USP Science Conclave
|
|
0
|
355
|
July 10, 2024
|
|
EPR Podcast Ep 26 – Navigating Nitrosamine Impurities
|
|
0
|
371
|
June 26, 2024
|
|
Predicting Nitrosamine Formation in the Solid State
|
|
3
|
724
|
June 24, 2024
|
|
Common Template for initial assessment of Nitrosamine impurities
|
|
0
|
659
|
June 20, 2024
|
|
Insights from the Lhasa Limited and IPEC Europe Nitrites collaborative meeting
|
|
1
|
510
|
June 16, 2024
|
|
🇺🇸 FDA - Fiscal Year 2024 Generic Drug Science and Research Initatives Public Workshop
|
|
20
|
1928
|
September 5, 2024
|